Sunitinib-induced severe hypothyroidism with cardiac compromise

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Collinson, Fiona J ^a   Vasudev, Naveen S ^a   Berkin, Liz ^a   Khan, Mohammed M ^a   Selby, Peter J ^a   Brown, Janet E ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Hypothyroidism; Renal cancer; Sunitinib

Indexed keywords

ALPHA INTERFERON; SUNITINIB; TEMSIROLIMUS; THYROXINE;

ADULT; ANAMNESIS; ARTICLE; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE SEVERITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FATIGUE; HORMONAL THERAPY; HUMAN; HYPOTHYROIDISM; KIDNEY CARCINOMA; LUNG METASTASIS; MALE; NEPHRECTOMY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SINUS NODE; SKIN DISCOLORATION; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 84655174959     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9757-z     Document Type: Article

References (9)

1. BI Rini I Tamaskar P Shaheen 2007 Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib J Natl Cancer Inst 99 81 83
2. J Desai L Yassa E Marqusee 2006 Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors Ann Intern Med 145 660 664 (Pubitemid 46768841)
3. F Torino SM Corsello R Longo 2009 Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy Nat Rev Clin Oncol 6 219 228
4. P Wolter C Stefan B Decallonne 2008 The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation Br J Cancer 99 448 454
5. TH Jones S Wadler 1998 Hupart KH: endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha Semin Oncol 25 54 63 (Pubitemid 28093156)
6. I Tamaskar R Bukowski P Elson 2008 Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib Ann Oncol 19 265 268 (Pubitemid 351201706)
7. Pinto P, Moreno V, Espinosa E, et al. New onset hypothyroidism and macrocytosis as surrogate markers for the efficacy of sunitinib in the treatment of advanced renal cell carcinoma. Presented at the American society of clinical oncology genitourinary cancers symposium, San Francisci, California, 5-7 March 2010.
8. Baldazzi V, Tassi R, Lapini A, et al. The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study. Urol Oncol. 2010 [Epub ahead of print].
9. PW Ladenson 1990 Recognition and management of cardiovascular disease related to thyroid dysfunction Am J Med 88 638 641 (Pubitemid 20192280)